Healthcare Deal Activity to Surge Amid Strong Market Conditions and US Tax Reform
Current market conditions and clarity about the US's new corporate tax rate to see global healthcare M&A rise to USD 418 billion in 2018.
Read More

Healthcare is one of the largest, fastest growing industries in the world. It's also the most regulated, with rapidly changing rules and regulations that often conflict from one country to another. Healthcare companies face trying to understand how these laws impact their market and M&A strategies while contending with rising R&D costs, loss of patent protection of blockbuster drugs, pricing pressures, and competition from generics. Rapid convergence of the healthcare and technology sectors requires even more legal expertise given the additional data privacy and intellectual property concerns.

  • Ranked Band 1 for Life Sciences, Chambers Asia Pacific
  • Best Global Healthcare Law Firm Award for Excellence in Product Liability Cases, Global Health & Pharma Magazine, 2015
  • Most Innovative Use of Technology for the Pharma MapApp, FT Most Innovative Lawyer Awards, 2015
  • No. 1 Healthcare M&A firm by deal volume for past five years, Thomson Reuters 2014
  • No. 1 Healthcare M&A firm by cross-border deal volume for past five years, Thomson Reuters 2014